H.R. 6757 · 117th Congress · House

Insulin Savings for Patients Act

Active· Referred to the Subcommittee on Health.
Introduced
Feb 18, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Insulin Savings for Patients Act

This bill requires 100% of negotiated price concessions for covered insulin products under the Medicare prescription drug benefit to be reflected at the point of sale by 2024. The Government Accountability Office must annually report on the effects of the bill's implementation, including with respect to insulin prices.

Action Timeline

5
  1. FEB 21, 2022•Committee

    Referred to the Subcommittee on Health.

  2. FEB 18, 2022•IntroReferral

    Introduced in House

  3. FEB 18, 2022•IntroReferral

    Introduced in House

  4. FEB 18, 2022•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. FEB 18, 2022•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

3

Health Subcommittee

hsif14

Referred: Feb 21, 2022

Active

Ways and Means Committee

hswm00

Referred: Feb 18, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Feb 18, 2022

Active